Sensorion reports its 2018 annual results. 75% of patients enrolled in the Sens-111 clinical trial. pdfRead

Sensorion strengthens its financial structure by issuing a €4.7 million nominal bond issue subscribed by new European investors and management. Bpifrance has selected Sensorion for its program "Hub Health Tech". pdfRead

Sensorion to present new SENS-401 data at ARO 2019 MidWinter Meeting, Feb. 9-13, 2019. pdfRead

Bilan semestriel du contrat de liquidité Sensorion avec la société de bourse Kepler Cheuvreux. pdfRead (in french only)

Sensorion Announces Publication of SENS-401 Data in Otology & Neurology Journal. pdfRead

Pipeline

20190603 pipeline

Enregistrer

Patient center

Corporate presentation

Next events